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Accepted 22 April 2011AbstractObjective: Minimally invasive surgery has been the trend in various specialties and continues to evolve as new technology develops. The
development of robotic surgery in gynecology remains in its infancy. The present study reports the first descriptive series of robotic surgery in
complicated gynecologic diseases in Taiwan.
Materials and Methods: From March 2009 to February 2011, the records of patients undergoing robotic surgery using the da Vinci Surgical
System were reviewed for patient demographics, indications, operative time, hospital stay, conversion to laparotomy, and complications.
Results: Sixty cases were reviewed in the present study. Forty-nine patients had benign gynecologic diseases, and 11 patients had malignancies.
These robot-assisted laparoscopic procedures include nine hysterectomy, 15 subtotal hysterectomy, 13 myomectomy, eight staging operation,
two radical hysterectomy, five ovarian cystectomy, one bilateral salpingo-oophorectomy and myomectomy, two resections of deep pelvic
endometriosis, one pelvic adhesiolysis, three sacrocolpopexy and one tuboplasty. Thirty-three patients had prior pelvic surgery, and one had
a history of pelvic radiotherapy. Adhesiolysis was necessary in 38 patients to complete the whole operation. Robotic myomectomy was easily
accomplished in patients with huge uterus or multiple myomas. The suturing of myometrium or cervical stump after ligation of the uterine
arteries minimized the blood loss. In addition, it was much easier to dissect severe pelvic adhesions. The dissection of para-aortic lymph nodes
can be easily accomplished. All these surgeries were performed smoothly without ureteral, bladder or bowel injury.
Conclusion: The present analyses include various complicated gynecologic conditions, which make the estimation of the effectiveness of robotic
surgery in each situation individually not appropriate. However, our experiences do show that robotic surgery is feasible and safe for patients
with complicated gynecologic diseases.
Copyright  2012, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
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Minimally invasive surgery has been the trend in various
specialties including gynecology for a long time and continues
to evolve as new technology develops. The development of
laparoscopy has been considered superior to laparotomy with
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1028-4559/$ - see front matter Copyright  2012, Taiwan Association of Obstetri
doi:10.1016/j.tjog.2012.01.005and less postoperative pain [1]. Despite the advantages over
laparotomy, the slow learning curve, less dexterity, limited
range of movement, counter-intuitive hand motions, two-
dimensional vision, ergonomic difficulty and tremor amplifi-
cation limit the application of laparoscopy in complex surgical
tasks [2], especially in those with suspected alteration in the
anatomical operating field or huge lesions occupying the
surgical space.
Since the approval by the US Food and Drug Administra-
tion (FDA) in April 2005, robotic surgeries using the da Vinci
Surgical System (Intuitive surgical Inc., Sunnyvale, CA, USA)
have been applied widely in many surgical fields includingcs & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
Table 1
Patient summary.
Patient Age (y) BMI Indication Prior surgery Robotic procedure TD Wt
1 36 21 Myoma, endometrioma of ovary e M, RAOC, adhesiolysis e e
2 31 19.2 Myoma e M d 150
3 55 22.6 Endometrial cancer e Staging operation (extrafascial
hysterectomyþBSOþBPPLND)
e e
4 39 19.9 Cervical cancer, stage IA1 e Staging operation (extrafascial
hysterectomyþBPPLND)
e e
5 40 18.7 Myoma e M e 230
6 35 23.7 Adenomyosis, myoma CS, laparoscopic adhesiolysis(3) RAVH, LSO, adhesiolysis e 158
7 67 27.7 Chronic pelvic pain CS RAVH, BSO, adhesiolysis e 48
8 49 25.9 Endometrial cancer CS Staging operation (extrafascial
hysterectomyþBSOþBPPLND), adhesiolysis
e e
9 40 21.8 Adenomyosis CS(3), appendectomy, salpingectomy RAVH, adhesiolysis e 160
10 44 19.9 Myoma e M e 125
11 60 22.5 Cervical cancer, stage IVB
post-chemoradiation therapy
e RAVH, BSO, pelvic and para-aortic lymph nodes
sampling
e e
12 51 19.4 Adenomyosis, myoma Tubal sterilization RAVH, BSO, adhesiolysis e 970
13 47 23.5 Myoma CS M e e
14 46 19 Myoma e M e e
15 38 19.4 Adenomyosis CS(2), laparoscopy SH, ligation of UA, adhesiolysis e e
16 41 22.7 Endometrial cancer e Staging operation (extrafascial
hysterectomyþBPPLND)
e e
17 41 17.7 Adenomyosis, myoma CS M, adhesiolysis 8 90
18 43 21.9 Adenomyosis, myoma LAOC(2), appendectomy SH, ligation of UA, adhesiolysis 7 190
19 35 18.4 Chronic pelvic pain CS Adhesiolysis 13 e
20 39 20 Adenomyosis, myoma M SH, ligation of UA, adhesiolysis 12 245
21 64 21.4 Prolapse of vaginal vault LAVHþBSO Sacrocolpopexy, adhesiolysis 4 e
22 45 30.2 Adenomyosis, myoma LAOC(2) SH, RSO, adhesiolysis 5 180
23 43 18.4 Myoma e SH 2 110
24 46 22.1 Endometrioma of ovary, myoma M(2), ovarian cystectomy BSO, adhesiolysis, M 7 40
25 37 18.6 Cervical cancer, stage IB1 e RH, BPPLND 2 e
26 63 26.9 Prolapse of uterus and anterior vaginal wall e Sacrocolpopexy, Burch colposuspension 6 e
27 39 20 Adenomyosis e SH, adhesiolysis 3 125
28 61 27.8 Cervical cancer, stage IB2 e RH, BSO, BPLND 3 e
29 51 20.2 Endometrial cancer M Staging operation (extrafascial
hysterectomyþBSOþBPPLND), adhesiolysis
5 e
30 48 26.2 Complex hyperplasia of endometrium,
adenomyosis, myoma
Laparoscopy, tubal sterilization RAVH, ligation of UA, adhesiolysis 3 1150
31 28 20 Myoma d M, adhesiolysis 4 30
32 29 22.8 Tubal obstruction Laparoscopic adhesiolysis Tuboplasty, adhesiolysis 4 e
33 56 34.1 Myoma e RAVH, BSO 4 370
34 40 34.6 Adenomyosis CS(3), laparoscopic drainage of TOA RAVH, LSO, adhesiolysis 3 210
35 56 22.3 Endometrial cancer LAVH Staging operation (BSOþBPPLND) 2 e
36 35 20 Adenomyosis, myoma CS, salpingectomy, laparoscopic colpopexy
þ pelvic adhesiolysis
SH, suspension of bilateral ovary, adhesiolysis 4 120
37 33 20.3 Endometrioma of ovary e RAOC, adhesiolysis 3 e
38 52 18.9 Myoma Oophorectomy SH, adhesiolysis 2 600
39 38 23.7 Myoma e M 4 200
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Table 1 (continued)
Patient Age (y) BMI Indication Prior surgery Robotic procedure TD Wt
40 45 25.7 Myoma CS, laparoscopic appendectomy, ovarian
cystectomy
RAVH, adhesiolysis 6 200
41 31 18.8 Myoma M M 7 60
42 34 20.6 Adenomyosis e SH, adhesiolysis 5 70
43 48 24.4 Prolapse of uterus Appendectomy Sacrocolpopexy, adhesiolysis 6 e
44 28 21 Endometrioma of ovary e RAOC, abscess drainage, salpingoplasty, adhesiolysis 6 e
45 29 21.9 Adenomyosis LAOC(2), appendectomy, CS SH, adhesiolysis 7 90
46 38 19.9 Myoma Laparoscopy SH 3 104
47 50 23.5 Myoma e SH, BSO 4 462
48 36 19.1 Myoma e M 4 71
49 36 29.1 Endometrial cancer Appendectomy, LAOC Staging operation (extrafascial
hysterectomyþBSOþBPPLND)
3 e
50 45 20.9 Myoma CS(2) SH, adhesiolysis 5 120
51 31 19.8 Pelvic endometriosis CS(2) Resection of pelvic endometriosis, adhesiolysis, ligation
of UA
4 e
52 46 33.7 Endometrial cancer Laparoscopy Staging operation (extrafascial
hysterectomyþBSOþBPPLND), adhesiolysis
3 e
53 40 22.4 Adenomyosis, bladder endometriosis e SH, adhesiolysis, resection of bladder endometriosis 5 90
54 31 20.4 Endometrioma of ovary e RAOC, resection of pelvic endometriosis, adhesiolysis,
tuboplasty
4 e
55 46 22.5 Myoma CS(2) M, adhesiolysis 4 170
56 33 26.8 Pelvic endometriosis Laparoscopy, adhesiolysis Resection of pelvic endometriosis, M, adhesiolysis, 8 e
57 27 21.5 Endometrioma of ovary e RAOC, resection of pelvic endometriosis, adhesiolysis 5 e
58 30 19.4 Teratoma of ovary e RAOC 5 e
59 42 21.5 Adenomyosis, endometrioma of ovary e SH, RAOC, adhesiolysis 3 202
60 34 19.2 Myoma LAOC, M, appendectomy M, adhesiolysis 3 70
Numbers in parentheses indicate the number of procedures. BMI, body mass index; BPLND, bilateral pelvic lymph node dissection; BPPLND, bilateral pelvic and paraaortic lymph node dissection; BSO, bilateral
salpingo-oophorectomy; CS, cesarean section; LAOC, laparoscopic-assisted ovarian cystectomy; LAVH, laparoscopic-assisted vaginal hysterectomy; LSO, left salpingo-oophorectomy; M, myomectomy; RAOC,
robotic-assisted ovarian cystectomy; RAVH, robotic-assisted vaginal hysterectomy; RH, radical hysterectomy; SH, subtotal hysterectomy; TD, docking time (min); TOA, tubo-ovarian abscess; UA, uterine artery;
Wt, weight of specimen (g).
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21S.-J. Tan et al. / Taiwanese Journal of Obstetrics & Gynecology 51 (2012) 18e25gynecology, urology, orthopedics, general surgery and
cardiothoracic surgery [3]. The three-dimensional vision
system and the wrist-like structure of EndoWrist instruments
(Intuitive surgical Inc., Sunnyvale, CA, USA) recapitulating
the motion of the surgeon’s hand make precise procedures
easier than in conventional laparoscopy, which allows robotic
surgery to overcome some of the shortcomings and limitations
of traditional laparoscopy [4]. However, the application of
robotic surgery in gynecology remains in its infancy, and its
indications are still undetermined. The present study reports
the first descriptive series of robotic surgery in complicated
gynecologic diseases in Taiwan.
Materials and methods
From March 2009 to February 2011, 60 patients with
complicated benign or malignant gynecologic surgical condi-
tions initially considered for laparotomy were admitted for
robotic gynecologic surgery, using the da Vinci Surgical
System by a single attending surgeon and rotating assistants.
Records were reviewed for patient demographics, indications,
operative time (defined as skin-to-skin time), hospital stay,
conversion to laparotomy, and complications.
All patients were positioned in a lithotomy position. A uterine
manipulator and a Foley catheter were inserted. Four or five
trocars were used after pneumoperitoneum was obtained. Trocar
sites varied according to different procedures. Generally, 3 cm
midline above the umbilicus for the scope and 8e10 cm lateral to
the scope at 15 degrees for the arms are the most commonly
adopted sites for surgical staging for endometrial cancer or
extended hysterectomy of cervical cancer. Scope at 30 is the
choice for para-aortic lymph node dissection up to the inferior
mesentery artery, while scope at 0 was used for the rest of the
procedures. The umbilicus could be used as the scope for benign
conditions. However, trocar sites at higher levels may be helpful
in patients with huge or multiple myomas or dense pelvic adhe-
sions, because of the better panoramic view and operation depth.Table 2
Procedure summary.
Major robotic procedure n Severe
adhesions
W
Hysterectomy 9 7 40
Subtotal hysterectomy 15 12 19
Myomectomy 13 6 11
Staging operation 8 3 e
Radical hysterectomy 2 0 e
Ovarian cystectomy 5d 4 e
Bilateral salpingo-oophorectomyþmyomectomy 1 1 e
Resection of pelvic endometriosisþ adhesiolysis 2 2 e
Pelvic adhesiolysis 1 1 e
Sacrocolpopexy 3 1 e
Tuboplasty 1 1 e
n, number of cases; Wt, weight of specimen (g).
a One case was excluded from this analysis, because of rehabilitation for nerve
b Two cases were excluded from this analysis, because of morcellator failure.
c Another two cases were excluded from this analysis: one underwent a course of
a result of occlusion of arteriovenous shunt.
d One case also underwent tuboplasty and drainage of tubo-ovarian abscess andThe accessory port could be 6e8 cm caudo-lateral or cephalo-
medial to the left arm. Once all ports were in place, the patient
was placed in a steepTrendelenburg position, and the patient-side
cartwas set between the patient’s legs, followed bydocking of the
robotic arms. Robotic surgery was performed with EndoWrist
instruments such as PreCise bipolar forceps, amonopolar cautery
spatula and needle drivers. A grasper, curved scissors or a mor-
cellator was used for assistance via an accessory port depending
on different procedures. A survey of the operative field was
performed, followed by themain procedure and other procedures
such as morcellation, adhesiolysis or ligation of uterine artery if
needed. After hemostasis and removal of the specimen via the
trocar site or by colpotomy, the arms were undocked and the
instruments were removed. Finally, the intra-abdominal gas was
released, and the trocar sites were closed with sutures.
Results
Sixty cases were reviewed in the present study. Forty-nine
patients had benign gynecologic diseases, and 11 patients
had malignancies (seven endometrial cancer and four cervical
cancer) (Table 1). A variety of robot-assisted laparoscopic
procedures included nine vaginal hysterectomy, 15 subtotal
hysterectomy with ligation of the uterine arteries, 13 myo-
mectomy, eight staging operation, two radical hysterectomy,
five ovarian cystectomy, one bilateral salpingo-oophorectomy
and myomectomy, two resection of deep pelvic endometriosis,
one pelvic adhesiolysis, three sacrocolpopexy and one tubo-
plasty. Thirty-three (55%) patients had prior pelvic surgery,
and one patient had a history of pelvic radiotherapy for
cervical cancer (Table 2). Extensive adhesiolysis was neces-
sary in 38 patients (63.3%) to complete the whole operation
(Fig. 1). We did not record the docking time until Patient 18.
The mean docking time from Patients 18 to 60 was 4.9 2.3
minutes.
In the robot-assisted laparoscopic vaginal hysterectomy
group, the mean age of the nine patients was 49.1 10.4 yearst Mean operation
time (min)
Blood loss (mL) Mean hospital
stay (d)
8.3 414.7 171.9 52.4 341.7 316.9 3.4 0.9a
3.4 153.8 162.9 62.2 140 94.9 3.2 0.8
9.6 66.2 206.8 67.7b 245 145.9 3.5 0.7
238.1 52.4 133.3 98.3 4.8 2.6c
363 29.7 750 990 8 1.4
109.2 20.4 62 21.7 3.4 2.1
223 600 4
139.5 27.6 150 4.5 0.7
136 50 3
166.7 69 53.3 83.7 3 1
184 100 4
injury.
chemotherapy after the operation; the other was treated with thrombectomy as
had a prolonged hospital stay of 7 d for antibiotic therapy.
Fig. 1. Pelvic adhesions. (A) Severe adhesions between the bladder and the anterior uterine wall after cesarean section. (B) Extensive adhesions at the left gutter
region.
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Seven patients (78%) had prior pelvic surgery-related pelvic
adhesions, including extensive pelvic adhesions in four
patients, and one had a history of pelvic radiotherapy. The
mean operative time was 171.9 52.4 minutes, and the mean
weight of specimen was 408.3 414.7 g. The mean blood loss
was 341.7 316.9 mL, and the mean length of hospital stay
was 3.4 0.9 days. A patient was complicated with common
peroneal nerve injury caused by positioning of the leg and was
excluded in the analysis of hospital stay because of her
rehabilitation program.
Fifteen patients with a mean age of 40.8 6.0 years and
mean BMI of 21.3 2.8 kg/m2 underwent robot-assisted
laparoscopic subtotal hysterectomy. Eight patients (53.3%)
had a history of pelvic surgery with resultant severe pelvic
adhesions, and four (26.7%) had pelvic adhesions without
a history of pelvic surgery. Four of the 15 patients were
nulliparous. Uterine arteries were dissected and cauterized for
the control of bleeding before supracervical hysterectomy. The
mean operative time was 162.9 62.2 minutes, and the mean
weight of specimen was 193.4 153.8 g. The mean blood loss
was 140 94.9 mL, and the mean length of hospitalization
was 3.2 0.8 days. One patient also had bladder endometri-
osis and underwent partial resection of bladder and primary
repair, followed by removal of the Foley catheter 1 week later.
There were 13 patients undergoing robot-assisted laparo-
scopic myomectomy. The mean age was 38.3 6.3 years, and
the mean BMI was 20.2 1.9 kg/m2. Of the 13 patients, six
(46.2%) had multiple huge myomas, one was associated with
bilateral ovarian endometrioma and severe pelvic adhesions,
and four had prior pelvic surgery with pelvic adhesions. The
mean operative time was 206.8 67.7 minutes, and two cases
were excluded in the analysis of operation time because of
dysfunction of the morcellator. The mean weight of specimen
was 119.6 66.2 g, and the mean blood loss was
245 145.9 mL. The mean hospital stay was 3.5 0.7 days.
A robot-assisted laparoscopic staging operation was per-
formed for eight patients with a mean age of 46.6 7.4 years
and a mean BMI of 24.6 4.8 kg/m2. Three had pelvic
adhesions as a result of prior pelvic surgery. The mean oper-
ative time was 238.1 52.4 minutes, and the mean blood loss
was 133.3 98.3 mL. The mean number of lymph nodesdissected were 18.8 11.0. The mean length of hospital stay
was 4.8 2.6 days. Two patients with other medical or
surgical conditions were excluded for the analysis of hospital
stay, including one undergoing chemotherapy and the other
with thrombectomy.
Two patients of cervical cancer underwent robot-assisted
laparoscopic radical hysterectomy. One took 384 minutes
with a blood loss of 1450 mL as a result of the bulky tumor
mass and need for blood transfusion. The other took
342 minutes with blood loss of 50 mL. The lymph nodes were
24 and 20, respectively. The mean length of hospital stay was
8 1.4 days.
Robot-assisted laparoscopic ovarian cystectomy was per-
formed for four patients with ovarian endometrioma and
extensive pelvic adhesions or posterior cul-de-sac obliteration.
One patient is with bilateral ovarian teratoma. One patient
with endometriosis, pelvic abscess and tubal obstructions at
the same times underwent drainage of tubo-ovarian abscess,
ovarian cystectomy and tuboplasty. The longer hospital stay
was for antibiotic therapy.
Robot-assisted laparoscopic resection of deep pelvic endo-
metriosis was done in two patients with chronic pelvic pain.
Both had complete obliteration of the posterior cul-de-sac
associated with endometriosis. We explored the rectovaginal
septum and excised deep endometriosis in uterosacral liga-
ments or the rectovaginal septum. The mean operative time was
139.5 27.6 minutes. The blood loss was 150 mL in both
cases. The mean length of hospital stay was 4.5 0.7 days.
Three patients with a mean age of 58.3 9.0 years and
a mean BMI of 24.2 2.8 kg/m2 underwent robot-assisted
laparoscopic sacrocolpopexy using Gynemesh. Two of them
were uterus-sparing sacrocolpopexy. The mean operative time
was 166.7 69.0 minutes, and the mean blood loss was
53.3 83.7 mL. The mean length of hospital stay was 3 1
days.
Discussion
In the present preliminary study, we evaluate the feasibility
of robotic surgery in various complicated gynecologic
diseases. It can be performed safely with acceptable operative
time and hospital stay, even in challenging situations which
23S.-J. Tan et al. / Taiwanese Journal of Obstetrics & Gynecology 51 (2012) 18e25are difficult and exhausting if using conventional laparoscopy.
Excellent dexterity afforded by the instruments and three-
dimensional vision help greatly to overcome the limitations
of conventional laparoscopy.
Hysterectomy could be approached by the vaginal or
abdominal route until the development of minimally invasive
surgery. The outcomes of laparoscopic hysterectomy have
been observed better than those after abdominal hysterectomy
[5]. However, abdominal hysterectomy remains the most
common route in patients with pelvic adhesions because of the
limitations of laparoscopy, such as less dexterity, limited range
of movement and two-dimensional visualization. In addition,
some factors including obesity, large uterine size, large
myoma, and a history of prior abdominal or pelvic surgery
make laparoscopic hysterectomy challenging and difficult [6].
With increasing experience of robotic surgery, gynecologic
surgeons can perform the operation more easily and smoothly.
Advincula and Reynolds first showed successful robot-assisted
laparoscopic hysterectomy in six patients who had a scarred or
obliterated anterior cul-de-sac as a result of previous cesarean
deliveries in 2005 [7]. They also reported a series of 16
patients who underwent either an American Association of
Gynecologic Laparoscopists (AAGL) type IVE hysterectomy
(totally laparoscopic removal of the uterus and cervix
including vaginal cuff closure) or a laparoscopic supracervical
hysterectomy (LSH) III hysterectomy (totally laparoscopic
supracervical procedure with removal of the uterine corpus
including division of the uterine arteries) with robotic assis-
tance having acceptable outcomes in 2006 [8]. In 2009,
Boggess illustrated the feasible application of robot-assisted
hysterectomy to benign gynecologic diseases with complex
pathology [9]. In our case series, most patients undergoing
robot-assisted laparosopic vaginal hysterectomy had prior
pelvic surgery and pelvic adhesions. We performed the robotic
surgery smoothly with minimal blood loss and without
ureteral, bladder or bowel injury. Technically, there should be
no problems in doing suturing using robotic EndoWrist
instruments. However, robotic vaginal cuff suturing has been
reported to be associated with a higher incidence of vaginal
cuff dehiscence [10]. There were no vaginal cuff dehiscences
in our series. Two layers of suturing may minimize this
complication. Suturing the vaginal cuff can be done by roboticFig. 2. Myomectomy. (A) The myomas were dissectedEndoWrist or through the vagina depending on surgeons’
experiences and preferences, and on patients’ perspectives
such as about the cost. Robot-assisted total laparoscopic
hysterectomy (TLH) using robotic needle drivers increases the
cost of consumables. Therefore, we did TLH in most patients,
but not in others.
Subtotal hysterectomy is an alternative for patients who do
not want to undergo total hysterectomy. Its advantages are still
being discussed and remain in controversy. Undoubtedly, this
procedure is more difficult than total hysterectomy when being
done by laparoscopy and needs well-skilled surgeons to
overcome the difficulties of the suturing and knot-tying with
laparoscopic instruments. With a robotic system, laparoscopic
subtotal hysterectomy can be performed safely, even in those
with prior pelvic surgery and pelvic adhesions [8]. The present
study also supports the advantages of subtotal hysterectomy
with robotic assistance. Easier dissection of tissue allows the
anatomy be clearly seen and helps to divide the uterine
arteries. Robot-assisted suturing and ligation of the uterine
arteries not only minimize the blood loss and burning fumes
caused by bleeding during the operation, but also reduce the
risk of postoperative cervical stump bleeding arising from
compromised suturing in conventional laparoscopy.
Laparoscopic myomectomy has been considered to have
some advantages compared with laparotomy, including
shortened hospitalization, less pain, and possibly reduced risk
of postoperative adhesions [11]. However, difficulty in
suturing the uterine incisions has troubled many gynecologic
surgeons. Since Advincula et al [12] reported the first expe-
rience of robot-assisted laparoscopic myomectomy in 2004,
many studies have demonstrated similar outcomes between
robotic and laparoscopic myomectomy but better performance
when removing myomas and closing the incised myometrium
layer by layer with robotic instruments [13]. In our experience,
robotic myomectomy can be easily accomplished in patients
with huge uterus or multiple myomas. The performance is
even more outstanding when dealing with multiple myomas
needing multiple incisions and suturing (Fig. 2), which may be
an exhausting task when being done by conventional lapa-
roscopy. In addition, it is much easier and more delicate to
dissect severe pelvic adhesions, especially in patients associ-
ated with endometriosis or multiple previous surgeries.with unipolar spatula. (B) Suturing of the uterus.
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by gynecologic oncologists for the treatment of endometrial
cancer. A large randomized trial showed laparoscopic surgical
staging is feasible and safe and has comparable outcomes to
laparotomy [14]. The latest reports demonstrated that robot-
assisted surgical staging has the advantages of less blood
loss and shorter hospital stay with similar complication rates
compared with conventional laparoscopic surgical staging
despite longer operative time [15,16]. In the present study, the
mean operative time is comparable to the preliminary expe-
rience reported by Reynolds et al (257 minutes) [17]. Since the
first robot-assisted laparoscopic radical hysterectomy reported
by Sert and Abeler [18], the case number has been growing. In
spite of variation in operator experience, many studies
demonstrate that robot-assisted radical hysterectomy results in
less blood loss and shorter hospital stay compared with lapa-
rotomy and traditional laparoscopy [19]. The dissection of
para-aortic lymph nodes up to inferior mesenteric artery and
pelvic lymph nodes down to the obturator fossa can be easily
accomplished without much bleeding, which is much easier
than conventional laparoscopic surgical staging. In addition,
better visualization by the three-dimensional vision makes
identification and manipulation of the ureters easier, protecting
them from iatrogenic injury. Our results demonstrated the
yield of lymph nodes equivalent to those performed by lapa-
rotomy with much less blood loss.
Laparoscopic sacrocolpopexy has been performed with
comparable results and decreased morbidity when compared
with laparotomy [20], but the requirement of well-skilled and
experienced surgeons limits its application. With the devel-
opment of robotic technology, a retrospective study comparing
robot-assisted laparoscopic sacrocolpopexy and abdominal
sacrocolpopexy showed comparable outcomes, less blood loss
and shorter hospital stay in the robotic group [21]. Our
experience also demonstrated short operative time, minimal
blood loss and reasonable length of hospitalization and
surgical outcome. However, long-term results are needed to
assess the durability of this new minimally invasive approach
for pelvic organ prolapse.
Pelvic endometriosis is the presence of endometrial glands
or stroma in the pelvis other than the uterine cavity and is
believed to be one of the major causes of chronic pelvic pain
in women of reproductive age. Surgical treatment of endo-
metriosis aims to remove all visible lesions and restore pelvic
anatomy by adhesiolysis. Meta-analysis has demonstrated
a statistically significant benefit of laparoscopic surgery for the
treatment of pelvic pain associated with endometriosis [22].
Nezhat et al also reported that there were no significant
differences in blood loss, hospitalization, intraoperative or
postoperative complications between robot-assisted laparo-
scopic and standard laparoscopic treatment of endometriosis
[23]. For most of our patients with either ovarian endome-
trioma or deep pelvic endometriosis or obliterated cul-de-sac,
we could complete the dissection without complications. All
patients experienced symptom improvement.
Obesity and adhesive diseases caused by various underlying
diseases or following pelvic surgical procedures are viewed asgreat challenges to laparoscopists and are often associated with
increased complication and conversion to laparotomy [15,24].
Leonard et al reported that 29 of 416 (7%) patients who
underwent total laparoscopic hysterectomy were converted to
laparotomy and 16 (55.2%) of the conversion cases were the
result of extensive adhesions [6]. In recent studies, acceptable
intra- and postoperative outcomes have been observed in obese
patients undergoing laparoscopic surgery [25]. George et al also
reported that obesity was not a risk factor for poor surgical
outcome with robotic surgery [26]. Furthermore, another study
supported that robotic surgery was superior to conventional
laparoscopy with less blood loss and shorter hospital stay in
obese patients [27]. Obesity per se is not a problem.
The present analyses include various complicated gyneco-
logic conditions, which make the estimation of the effectiveness
of robotic surgery in each situation individually not appropriate.
However, our experiences do show that robotic surgery is feasible
and safe for patients with either benign ormalignant gynecologic
disease even in complicated conditions like severe pelvic adhe-
sions. The ease of operating the robotic systemmayovercome the
limitations and long learning curve of conventional laparoscopic
surgery in complicated conditions (which are either not possible
by conventional laparoscopy or can be accomplished by only
a few surgeons). It ismore appropriate to specify a learning curve
on a specific procedure considering various confounding factors
such as surgeon’s training background and experiences in lapa-
roscopy or laparotomy. Since this report includes various
procedures, the description of learning curve may be quite
subjective. The success of robotic surgery depends on a team-
work. How to establish a robotic gynecologic surgery team is an
important issue, especially at the beginning. Indeed, there have
been reports showing that a gynecologist can master robotic
surgical staging in 20 patients [28]. A study also demonstrated
that there was no significant difference between novice and
expert laparoscopists when learning tomaster an operation using
the da Vinci Surgical system [29]. Further research about the
learning curve in different settings for different procedures by
different doctors with different training background would be
warranted. How to establish and integrate the training of robotic
surgery in the training program of general gynecology or gyne-
cologic oncology should be considered in the coming future.
Obstacles such high cost, bulkiness of the device, loss of haptic
feedback, inconvenience for the assistant to manipulate the
uterus and to exchange instruments can be overcome as the
robotic technology evolves. More evidence is mandatory to
evaluate the role of robotic surgery in different surgical indica-
tions and its cost-effectiveness in different healthcare systems.
In conclusion, the widespread use and the continuing
evolution of robotic surgery may further change the picture of
gynecologic surgery in the future. How to delineate the indi-
cations and integrate robotic surgery into current training
programs in Taiwan warrants further investigations.
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